Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Sun Island Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturer established in 1993 and headquartered in Haikou, Hainan Province. The company specializes in the development and production of generic medications across multiple therapeutic areas, including anti-infectives, gastrointestinal treatments, and metabolic health. Its diverse product portfolio features widely used medicines such as Roxithromycin, Amoxicillin, Gliquidone, and Famotidine, all manufactured in GMP-certified facilities. Sun Island Pharmaceutical maintains robust manufacturing capabilities for a variety of oral dosage forms, including capsules, tablets, and granules. Primarily serving the domestic Chinese market, the company focuses on providing high-quality generic solutions for common clinical needs. It operates as a comprehensive pharmaceutical entity with a long-standing presence in the regional pharmaceutical hub of Hainan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Sun Island Pharmaceutical.